Future Covid-like pandemic inevitable, Worcestershire virologist warns
Five years after the first coronavirus lockdown in the UK, a virus expert has warned the UK will almost certainly see another pandemic at some point in the future.Prof Lawrence Young, a virologist, said coronavirus was under control at the moment but "we've just got to keep an eye on it".He also said he believed the pandemic had shaken the world out of complacency and shown the value of advancing medical technology, lateral flow tests and a joined up approach to infectious diseases.But he worried that, with the financial pressures on the NHS, "we're somehow losing the momentum around public health".
Since the peak of the pandemic, new variants of Covid have emerged.Prof Young, who lives in Worcestershire, said the number of coronavirus hospitalisations had been "fortunately quite low" this winter.He said there was a growing hope that it would settle down to become a seasonal winter virus.But he warned: "It's still lurking and we need to be aware it could cause a new wave if we're not careful."For those more likely to become seriously ill from Covid, the NHS offers a free booster shot.Vaccines have been updated to better match recent variants.
Prof Young, who retired in 2024 from the University of Warwick, said coronavirus could still be very dangerous to elderly or vulnerable people and vaccines remained important.Climate change and the availability of international travel and mixing made it easier for viruses to spread, he said, adding "we will be inevitably faced with pandemics in the future".
The Covid inquiry has been holding hearings since 2023, taking evidence from politicians, civil servants and health experts about the roll-out of vaccines and anti-viral treatment across the UK.In July 2024, the inquiry's first report said the UK's flawed pandemic preparations had led to more deaths and greater economic damage than there should have been.Looking back at what lessons he felt have been learned since the first lockdown was announced in 2020, Prof Young said he believed the world had seen the value of monitoring, testing, tracing and isolating.He also said: "I think this whole pandemic has highlighted the importance of individual responsibility in preventing the spread of infection and protecting the most vulnerable."That included measures such as the wearing of face masks, which he noted was "commonplace in the Far East".He also believed the pandemic was important because it had "shaken us out of the complacent view that we needn't be concerned about the dangerous of infectious disease".
Follow BBC Hereford & Worcester on BBC Sounds, Facebook, X and Instagram.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
North Wales Chronicle
an hour ago
- North Wales Chronicle
Surgeons from Europe observe robotic knee surgery at Ysbyty Gwynedd
The surgeons, from Poland, Slovakia, Romania and the United Kingdom have been observing the operations carried out by Consultant Orthopaedic Surgeon Muthu Ganapathi. Ysbyty Gwynedd, in Bangor, has been pioneering robotic knee replacements since 2022 and is the only NHS hospital in Wales to offer this type of surgery. Mr Ganapathi along with colleagues Agustin Soler, Koldo Azura, Amir Azam and Ashok Goel have now carried out more than 250 robotic knee replacements using the ROSA robotic system. Mr Ganapathi said: 'There has been a paradigm shift in how a knee replacement is carried out. 'Traditionally the bone cuts were made with a 'one shape fit all' approach but there is increasing recognition that a personalised approach maybe better. With this type of approach, the bone cuts are personalised to match as closely to the individual patient's knee shape. The precision of the robot allows us to do the personalised bone cuts.' The ROSA being used by surgeons Mr Ganapathi and Mr Soler during a procedure in theatres at Ysbyty Gwynedd. (Image: BCUHB) 'With this personalised approach the recovery seems to be faster and less painful compared to traditional knee replacements.' Sion Quinn, Clinical Lead for Trauma and Orthopaedic Physiotherapy at Ysbyty Gwynedd, said: 'Since the establishment of robotic surgery we have seen patients recovering faster with less pain after their knee replacements. 'Within the NHS we are always looking at ways to improve the patient experience and with the introduction of these robotic knees we have seen improvement in patient outcomes.' MORE NEWS How much was spent on failed Denbighshire Leisure sale – full cost breakdown Man 'trapped' in vehicle taken to hospital after St Asaph crash Last year, Zimmer Biomet (ROSA robot) recognised Ysbyty Gwynedd as an official training centre for robotic knee replacements for surgeons across the UK and Europe which has led to interest further afield in this type of procedure. The use of the robot has also created further benefits by establishing an industry funded advanced Hip and Knee Robotic Fellowship role at Ysbyty Gwynedd. This provides the opportunity for senior surgeons across the UK to work with the robotic team for six months and get trained in robotics before applying for their Consultant posts. Orthopaedic Surgeon, Ashok Singh, who is the current Robotic Fellow has already completed his Orthopaedic training in London and chose this fellowship to advance his skills. He said: 'I was attracted to this Fellowship as the skill sets it offered was unique for this fellowship. It isn't just the robotic technique I am having the opportunity to learn it is also other techniques such as the direct anterior approach which is a minimally invasive technique for total hip arthroplasty and Oxford Uni knees. 'I am really enjoying this Fellowship, the personalised knee replacement technique with robotics has been extremely beneficial and I have seen excellent results. So, it's something I will definitely be using in my practice as I develop in my career.' Mr Ganapathi added: 'We are delighted with the feedback we are receiving from our Fellows since it was established last year – it's been such a positive experience for them and us as Consultants. 'The ROSA has helped us put Ysbyty Gwynedd and the Health Board on the map for innovation and how we are constantly trying to improve our service and ensure we always have the best outcomes for our patients.'
Daily Mirror
an hour ago
- Daily Mirror
Doctor shares six symptoms of new Covid strain sweeping UK with key warning
A doctor has outlined the key signs we need to look out for in the new Covid variant known as 'Nimbus' as cases spike across the UK, with the strain also been found in 21 other countries worldwide A new strain of coronavirus is sweeping across the UK, and symptoms vary, but some are 'not typical' of former Covid cases. The new variant, known as NB.1.8.1, has been named 'Nimbus' and is causing a spike in cases across the nation. As of yesterday, 13 cases of the virus have been confirmed in the UK, prompting concern from health professionals. According to the UK Health Security Agency (UKHSA), it is making up a "growing proportion" of Covid cases worldwide, as China and Hong Kong have seen a surge in cases, with the strain also identified in 21 other countries. The symptoms of 'Nimbus' can vary and are largely consistent with previous forms of the virus, but there are six key signs to look out for. Director & Superintendent Pharmacist, Prescription Doctor, Mohamed Imran Lakhi, exclusively tells the Mirror:"People commonly report a severe sore throat, persistent fatigue, mild cough, fever, muscle aches, and nasal congestion. "Some also experience digestive issues like nausea or diarrhoea, which isn't always typical with Covid variants." With a spike in cases of the 'Nimbus' strain across the UK, Dr Lakhi explains how we can best protect ourselves. He said: "While it seems to spread more easily, there's no strong evidence so far that it causes more severe illness than previous versions. Vaccines, especially those updated for Omicron strains, still offer good protection against serious disease. "It's important to stay up to date with your vaccinations and follow basic precautions like hand hygiene and wearing masks in crowded spaces, particularly as this variant circulates. "If you or someone you know develops these symptoms, especially the sore throat and fatigue, it's wise to get tested and isolate until you know more. Early detection helps protect you and those around you." The World Health Organisation (WHO) added the new Covid strain to its official watch list, amid fears it could be more contagious than earlier forms of the virus. However, there's currently no proof that it leads to more severe illness. According to WHO, the strain first appeared in January and by late April it was responsible for around 10.7% of global infections, up from just 2.5% a month earlier. Ireland has witnessed a sharp increase in cases linked to this variant in recent weeks. According to data from the Health Protection Surveillance Centre (HPSC), the proportion of sequenced Covid samples linked to NB.1.8.1 jumped from 3.7% to 27.3% in the last five weeks, reports Dublin Live.
Daily Mail
an hour ago
- Daily Mail
US investment consortium wins £1.7bn battle for NHS landlord
Healthcare property firm Assura Group is set to be acquired by a consortium of US private equity firms after they trumped a rival bid. The increased 'best and last' cash offer of £1.7billion from private equity groups KKR and Stonepeak will be recommended to shareholders as Assura's top brass rejected a rival proposal from Primary Health Properties. The rival proposal PHP valued Assura at approximately £1.68billion. Assura is the latest in a growing list of British businesses being bought out and taken private by overseas private equity firms or investment companies, attracted by cheap valuations. Assura said that private ownership would enable it to secure new funding and invest in healthcare infrastructure, without the pressure of public market expectations. Both Assura and PHP own doctors' surgeries, hospitals and hospices across the UK, and are major landlords to the NHS. KKR, one of the biggest private equity outfits in the US, teamed up with New York investment firm Stonepeak to get the deal over the line. Via their Sana 'bidco' vehicle, KKR and Stonepeak hiked their final offer to 52.1p per share in cash, including two 0.84p dividends. This represented a 39.2 per cent premium to the pre-offer price. After weeks of due diligence into the PHP offer, directors of the healthcare property developer concluded that the bid presented 'material risks and downsides to Assura shareholders', including over-leverage and uncertainty around planned asset disposals. The revised offer from Sana will now proceed via a takeover offer, increasing deal certainty, with antitrust clearances already secured in China, Israel and South Korea, Assura said on Wednesday. Assura chair Ed Smith, said: 'The board's decision to recommend the offer from KKR and Stonepeak follows a careful and thorough evaluation of both offers, during which the board has been firmly focused on its fiduciary duty to shareholders.' 'KKR and Stonepeak are highly experienced investors in healthcare and infrastructure and I am confident that with their support, and the additional capital they will provide, Assura will continue to deliver the high-quality healthcare infrastructure our communities need.' Andrew Furze, managing director at KKR, said: 'After nearly a year of engagement, this is our best and final offer which we believe is lower risk than other alternatives and higher in value offering a significant premium. 'We require no disposals to achieve our ambition and importantly the all cash offer poses minimal execution risk.' Blackrock is the biggest holder of Assura shares, with 9.9 per cent of the equity. L&G, Aberdeen and Quilter are all among the top ten shareholders. Last summer, Assura announced the £500million acquisition of a portfolio of 14 private hospitals from a Canadian REIT. The hospitals are spread throughout Britain, though with a concentration towards London, and were let on long leases to a number of private healthcare providers. Assura shares rose 2.04 per cent or 1.00p to 49.90p on Wednesday, having risen around 27 per cent in the last year.
